{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:45Z","timestamp":1793060025060,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High hepatitis E (HEV) seroprevalence has been reported in the general population and in post-liver transplant (LT) cases in several regions, including Thailand, with genotype 3 being a predominant genotype. We hypothesized that HEV might persist at a subclinical level and might pose clinical risks in the post-LT period. We performed a cross-sectional study with 108 post-LT patients and found an IgG seroprevalence of 55.6%. Subsequently, 91 cases without clinical evidence of HEV-related hepatitis were enrolled in 1 year of prospective follow-up to determine clinical status, serologies and serum\/feces HEV RNA every 4 months. HEV RNA was detected, indicating subclinical infections in patients with or without seropositivity, with an annual incidence of 7.7%. Our results suggest that subclinical HEV infection exists among LT patients in this high-prevalence area. Thus, clinicians should be aware of the possibility of disease reemergence and HEV viral transmission in LT patients.<\/jats:p>","DOI":"10.1038\/s41598-020-64551-x","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T10:03:55Z","timestamp":1588241035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study"],"prefix":"10.1038","volume":"10","author":[{"given":"Piyawat","family":"Komolmit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Oranrap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinporn","family":"Suksawatamnuay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kessarin","family":"Thanapirom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachaya","family":"Sriphoosanaphan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunthiya","family":"Srisoonthorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawarat","family":"Posuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanunrat","family":"Thongmee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombat","family":"Treeprasertsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Poovorawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"64551_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/lt.21480","volume":"14","author":"EB Haagsma","year":"2008","unstructured":"Haagsma, E. B. et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 14, 547\u2013553 (2008).","journal-title":"Liver Transpl."},{"key":"64551_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJMc0903778","volume":"361","author":"HR Dalton","year":"2009","unstructured":"Dalton, H. R., Bendall, R. P., Keane, F. E., Tedder, R. S. & Ijaz, S. Persistent carriage of hepatitis E virus in patients with HIV infection. N. Engl. J. Med. 361, 1025\u20131027 (2009).","journal-title":"N. Engl. J. Med."},{"key":"64551_CR3","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","volume":"379","author":"N Kamar","year":"2012","unstructured":"Kamar, N. et al. Hepatitis E. Lancet 379, 2477\u20132488 (2012).","journal-title":"Lancet"},{"key":"64551_CR4","first-page":"e15618","volume":"14","author":"Y Geng","year":"2014","unstructured":"Geng, Y. et al. Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia. Hepat. Mon. 14, e15618 (2014).","journal-title":"Hepat. Mon."},{"key":"64551_CR5","first-page":"577","volume":"111","author":"S Pischke","year":"2014","unstructured":"Pischke, S. et al. Hepatitis E in Germany\u2013an under-reported infectious disease. Dtsch. Arztebl. Int. 111, 577\u2013583 (2014).","journal-title":"Dtsch. Arztebl. Int."},{"key":"64551_CR6","doi-asserted-by":"publisher","first-page":"e0126184","DOI":"10.1371\/journal.pone.0126184","volume":"10","author":"P Sa-nguanmoo","year":"2015","unstructured":"Sa-nguanmoo, P. et al. Swine is a possible source of hepatitis E virus infection by comparative study of hepatitis A and E seroprevalence in Thailand. PLoS One 10, e0126184 (2015).","journal-title":"PLoS One"},{"key":"64551_CR7","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3201\/eid1810.111756","volume":"18","author":"MS Faber","year":"2012","unstructured":"Faber, M. S. et al. Hepatitis E virus seroprevalence among adults, Germany. Emerg. Infect. Dis. 18, 1654\u20131657 (2012).","journal-title":"Emerg. Infect. Dis."},{"key":"64551_CR8","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/JCM.00235-07","volume":"45","author":"A Boutrouille","year":"2007","unstructured":"Boutrouille, A., Bakkali-Kassimi, L., Cruciere, C. & Pavio, N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J. Clin. Microbiol. 45, 2009\u20132010 (2007).","journal-title":"J. Clin. Microbiol."},{"key":"64551_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1017\/S0950268807008941","volume":"136","author":"M Bouwknegt","year":"2008","unstructured":"Bouwknegt, M. et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiol. Infect. 136, 567\u2013576 (2008).","journal-title":"Epidemiol. Infect."},{"key":"64551_CR10","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","volume":"61","author":"P Behrendt","year":"2014","unstructured":"Behrendt, P., Steinmann, E., Manns, M. P. & Wedemeyer, H. The impact of hepatitis E in the liver transplant setting. J. Hepatol. 61, 1418\u20131429 (2014).","journal-title":"J. Hepatol."},{"key":"64551_CR11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/jmv.24251","volume":"87","author":"A Avellon","year":"2015","unstructured":"Avellon, A., Morago, L., Garcia-Galera Del Carmen, M., Munoz, M. & Echevarria, J. M. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J. Med. Virol. 87, 1934\u20131939 (2015).","journal-title":"J. Med. Virol."},{"key":"64551_CR12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jcv.2013.10.010","volume":"58","author":"SD Pas","year":"2013","unstructured":"Pas, S. D. et al. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. J. Clin. Virol. 58, 629\u2013634 (2013).","journal-title":"J. Clin. Virol."},{"key":"64551_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.ebiom.2015.09.030","volume":"2","author":"Y Inagaki","year":"2015","unstructured":"Inagaki, Y. et al. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan. EBioMedicine 2, 1607\u20131612 (2015).","journal-title":"EBioMedicine"},{"key":"64551_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3201\/eid1701.100527","volume":"17","author":"F Legrand-Abravanel","year":"2011","unstructured":"Legrand-Abravanel, F. et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg. Infect. Dis. 17, 30\u201337 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"64551_CR15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1053\/j.gastro.2012.02.014","volume":"142","author":"H Wedemeyer","year":"2012","unstructured":"Wedemeyer, H., Pischke, S. & Manns, M. P. Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 142, 1388\u20131397.e1381 (2012).","journal-title":"Gastroenterology"},{"key":"64551_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/v8080211","volume":"8","author":"J Hartl","year":"2016","unstructured":"Hartl, J. et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses 8, 211 (2016).","journal-title":"Viruses"},{"key":"64551_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar, N. et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 358, 811\u2013817 (2008).","journal-title":"N. Engl. J. Med."},{"key":"64551_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/trf.15041","volume":"59","author":"D Intharasongkroh","year":"2019","unstructured":"Intharasongkroh, D. et al. Hepatitis E virus infection in Thai blood donors. Transfusion 59, 1035\u20131043 (2019).","journal-title":"Transfusion"},{"key":"64551_CR19","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/jmv.24251","volume":"87","author":"A Avellon","year":"2015","unstructured":"Avellon, A., Morago, L., Garcia-Galera del Carmen, M., Munoz, M. & Echevarria, J. M. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol 87, 1934\u20131939 (2015).","journal-title":"J Med Virol"},{"key":"64551_CR20","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/jmv.22036","volume":"83","author":"A Khan","year":"2011","unstructured":"Khan, A. et al. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol 83, 622\u2013629 (2011).","journal-title":"J Med Virol"},{"key":"64551_CR21","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3201\/eid2108.141995","volume":"21","author":"S Grierson","year":"2015","unstructured":"Grierson, S. et al. Prevalence of hepatitis E virus infection in pigs at the time of slaughter, United Kingdom, 2013. Emerg. Infect. Dis. 21, 1396\u20131401 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"64551_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00705-010-0751-8","volume":"155","author":"K Suwannakarn","year":"2010","unstructured":"Suwannakarn, K., Tongmee, C., Theamboonlers, A., Komolmit, P. & Poovorawan, Y. Swine as the possible source of hepatitis E virus transmission to humans in Thailand. Arch. Virol. 155, 1697\u20131699 (2010).","journal-title":"Arch. Virol."},{"key":"64551_CR23","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/jmv.21553","volume":"81","author":"M Kaba","year":"2009","unstructured":"Kaba, M. et al. Frequent transmission of hepatitis E virus among piglets in farms in Southern France. J. Med. Virol. 81, 1750\u20131759 (2009).","journal-title":"J. Med. Virol."},{"key":"64551_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/lt.21958","volume":"16","author":"S Pischke","year":"2010","unstructured":"Pischke, S. et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl. 16, 74\u201382 (2010).","journal-title":"Liver Transpl."},{"key":"64551_CR25","doi-asserted-by":"publisher","first-page":"1800386","DOI":"10.2807\/1560-7917.ES.2019.24.10.1800386","volume":"24","author":"H Harvala","year":"2019","unstructured":"Harvala, H. et al. Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening. Euro Surveill. 24, 1800386 (2019).","journal-title":"Euro Surveill."},{"key":"64551_CR26","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.3201\/eid1712.110371","volume":"17","author":"M Jean-Michel","year":"2011","unstructured":"Jean-Michel, M. et al. Hepatitis E Virus Antibodies in Blood Donors, France. Emerging Infectious Disease journal 17, 2309 (2011).","journal-title":"Emerging Infectious Disease journal"},{"key":"64551_CR27","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/ajt.12253","volume":"13","author":"N Kamar","year":"2013","unstructured":"Kamar, N., Rostaing, L., Legrand-Abravanel, F. & Izopet, J. How should hepatitis E virus infection be defined in organ-transplant recipients? Am. J. Transpl. 13, 1935\u20131936 (2013).","journal-title":"Am. J. Transpl."},{"key":"64551_CR28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/infdis\/jiy603","volume":"219","author":"Y Choi","year":"2019","unstructured":"Choi, Y., Zhang, X. & Skinner, B. Analysis of IgG anti-HEV antibody protective levels during hepatitis E virus reinfection in experimentally infected Rhesus macaques. J. Infect. Dis. 219, 916\u2013924 (2019).","journal-title":"J. Infect. Dis."},{"key":"64551_CR29","first-page":"1355","volume":"341","author":"MS Khuroo","year":"1993","unstructured":"Khuroo, M. S., Kamili, S., Dar, M. Y., Moecklii, R. & Jameel, S. Hepatitis E and long-term antibody status. Lancet 341, 1355 (1993).","journal-title":"Lancet"},{"key":"64551_CR30","doi-asserted-by":"publisher","first-page":"e0186858","DOI":"10.1371\/journal.pone.0186858","volume":"12","author":"MA Risalde","year":"2017","unstructured":"Risalde, M. A. et al. Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar. PLoS One 12, e0186858 (2017).","journal-title":"PLoS One"},{"key":"64551_CR31","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jhep.2011.06.021","volume":"56","author":"B Schlosser","year":"2012","unstructured":"Schlosser, B. et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J. Hepatol. 56, 500\u2013502 (2012).","journal-title":"J. Hepatol."},{"key":"64551_CR32","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1136\/gut.2008.165571","volume":"58","author":"P le Coutre","year":"2009","unstructured":"le Coutre, P. et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 58, 699\u2013702 (2009).","journal-title":"Gut"},{"key":"64551_CR33","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/infdis\/jiu032","volume":"209","author":"F Abravanel","year":"2014","unstructured":"Abravanel, F. et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J. Infect. Dis. 209, 1900\u20131906 (2014).","journal-title":"J. Infect. Dis."},{"key":"64551_CR34","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/hep.24738","volume":"55","author":"PV Suneetha","year":"2012","unstructured":"Suneetha, P. V. et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 55, 695\u2013708 (2012).","journal-title":"Hepatology"},{"key":"64551_CR35","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1073\/pnas.1705446114","volume":"114","author":"D Cao","year":"2017","unstructured":"Cao, D. et al. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity. Proc. Natl. Acad. Sci. USA 114, 6914\u20136923 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64551_CR36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3201\/eid1905.121845","volume":"19","author":"SA Baylis","year":"2013","unstructured":"Baylis, S. A. et al. World Health Organization international standard to harmonize assays for detection of hepatitis E virus RNA. Emerg. Infect. Dis. 19, 729\u2013735 (2013).","journal-title":"Emerg. Infect. Dis."},{"key":"64551_CR37","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1111\/trf.14285","volume":"57","author":"NJ Roth","year":"2017","unstructured":"Roth, N. J. et al. Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors. Transfusion 57, 2958\u20132964 (2017).","journal-title":"Transfusion"},{"key":"64551_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/lt.21926","volume":"16","author":"EB Haagsma","year":"2010","unstructured":"Haagsma, E. B., Riezebos-Brilman, A., Van den Berg, A. P., Porte, R. J. & Niesters, H. G. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl. 16, 474\u2013477 (2010).","journal-title":"Liver Transpl."},{"key":"64551_CR39","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","volume":"370","author":"N Kamar","year":"2014","unstructured":"Kamar, N. et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N. Engl. J. Med. 370, 1111\u20131120 (2014).","journal-title":"N. Engl. J. Med."},{"key":"64551_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","volume":"150","author":"VL Dao Thi","year":"2016","unstructured":"Dao Thi, V. L. et al. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. Gastroenterology 150, 82\u201385 e84 (2016).","journal-title":"Gastroenterology"},{"key":"64551_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jviromet.2005.07.004","volume":"131","author":"N Jothikumar","year":"2006","unstructured":"Jothikumar, N., Cromeans, T. L., Robertson, B. H., Meng, X. J. & Hill, V. R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 131, 65\u201371 (2006).","journal-title":"J. Virol. Methods"},{"key":"64551_CR42","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1128\/JCM.40.9.3209-3218.2002","volume":"40","author":"H Mizuo","year":"2002","unstructured":"Mizuo, H. et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol. 40, 3209\u20133218 (2002).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64551-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:41:48Z","timestamp":1670319708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-64551-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["64551"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-64551-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7352"}}